HLA-DP/DR Antikörper (APC)
Kurzübersicht für HLA-DP/DR Antikörper (APC) (ABIN3200231)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Reacts with alpha/beta dimer as well as with dissociated beta-subunit of human HLA-DR and HLA-DP
-
Aufreinigung
- Purified (liquid chromatography)
-
Immunogen
- PHA-activated peripheral blood lymphocytes.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- FC: 10 μL for 100 μL of whole blood or 10^6 cells in suspension -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, BSA 0.2 % (w/v), Sodium azide 15 mM
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light.
-
-
- HLA-DP/DR (MHC Class II HLA-DP/DR (HLA-DP/DR))
-
Andere Bezeichnung
- HLA-DR+DP
Target
-